TB
Telesis Bio, Inc.
TBIO · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $78.4K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 61.13%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 173.49%
Op. margin 169.18%
FCF margin 133.22%
Quality
7 /100
Poor ROA 67.78%
Asset turnover 0.39x
ROIC 72.70%
Debt
44 /100
Moderate Current ratio 3.71x
Int. coverage -14.36x
Debt/Equity 1.16x
Stability
7 /100
Unstable Rev. volatility 74.18%
EPS volatility 61.79%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na TBIO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Eric Esser
Employees
39
Headquarters
San Diego
Nadcházející události
17 LIS
Earnings
Upcoming earnings report